AzTrials
AzTrials

Cesarean SectionNCT02839005

Absorbable Suture Versus Nonabsorbable Suture Intradermal for the Skin Transverse Section in Cesarean

A study testing Continuous suture with polyglecaprone 25 and Continuous suture with polyamide (nylon) in people with Cesarean Section and Sutures, run by Universidade do Vale do Sapucai at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Context: Cesarean section is the most common surgery in women, both in developed and underdeveloped countries. However results are conflicting report in which material for intradermal suturing get better aesthetic result. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Cesarean Section, Sutures
What is being tested?
Continuous suture with polyglecaprone 25 and Continuous suture with polyamide (nylon)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteBrazil
Study dates
Apr 2015to Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who underwent cesarean section
  • No restriction of ethnicity, education or social class

Who cannot join

  • Scarring Pfannenstiel prior
  • Diabetic patients using drugs;
  • Patients with collagen diseases
  • Patients with pre operative tests to indicate any systemic sign of infection or site, not previously treated until the time of surgery.
  • Patients who withdrew informed consent
  • Patients who did not attend the pre scheduled dates for the controls after surgery .

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital das Clínicas Samuel Libânio

    Pouso Alegre, Minas Gerais, 37550-000

Other trials in Brazil

About this study

Context: Cesarean section is the most common surgery in women, both in developed and underdeveloped countries. However results are conflicting report in which material for intradermal suturing get better aesthetic result. Objective: To compare the aesthetic appearance of two suture materials, polyglecaprone 25 and polyamide (nylon) with intradermal sutures for skin closure in women undergoing cesarean section first. Methods: This is a clinical, prospective and randomized study which was conducted in the Department of Gynecology and Obstetrics of a tertiary Institute, Hospital das Clinicas Samuel Libânio, in PousoAlegre, Estate of Minas Gerais. Sixty women undergoing cesarean section were first included and randomized into two groups: group I (n = 30) polyamide and group II (n = 30) polyglecaprone 25. Hypertrophy, color and width of the wound were evaluated, receiving a score, according to Trimbos table, six months after surgery. Later the results were compared to non-parametric statistical tests

Being tested
Continuous suture with polyglecaprone 25, Continuous suture with polyamide (nylon)
Keywords
Wound Closure Thechnical, Wound Healing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Continuous suture with polyglecaprone 25Other

    At the end of surgical procedemento of cesarean delivery , for skin closure continuous suture was performed with polyglecaprone 25

  • Continuous suture with polyamide (nylon)Other

    At the end of surgical procedemento of cesarean delivery , for skin closure continuous suture was performed with polyamide (nylon)

Study groups in NCT02839005
Study groupRoleWhat they receive
suture with polyglecaprone 25Active comparatorNot described
Receives: Other: Continuous suture with polyglecaprone 25
suture with polyamide (nylon)Active comparatorNot described
Receives: Other: Continuous suture with polyamide (nylon)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Photographic documentation for evaluation

    The photographic record was sent to three experts for evaluation of hypertrophy and cross marks staining points, according Trimboset al.,1993

    Measured: 6 Months

  2. Photographic documentation for evaluation

    The photographic record was sent to another expert for evaluation of hypertrophy and cross marks staining points, according Trimboset al.,1993, besides scar mesure

    Measured: 6 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2016 (estimated)
  2. Study startApr 2015
  3. Primary completionJan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02839005
Sponsor's protocol ID
MRJ
Status last verified
Jul 2016
First submitted
18 Jul 2016
Last updated
20 Jul 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Continuous suture with polyglecaprone 25 and Continuous suture with polyamide (nylon) in people with Cesarean Section and Sutures, run by Universidade do Vale do Sapucai at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Photographic documentation for evaluation (time frame: 6 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in